Accolade completed the acquisition of 2nd.MD for $460m.

Accolade, a healthcare service company, completed the acquisition of 2nd.MD, a healthcare opinion services provider, for $460m. “We share a common vision to help every person live their healthiest life by dramatically improving quality and accessibility of care through a people-focused, clinically-driven support model. Bringing 2nd.MD’s world-class Care Team and digital approach with expert medical consultation into Accolade, and continuing to offer it on a stand-alone basis, will have an immediate and measurable impact for our customers, their employees, and the health plans we work with. With the addition of 2nd.MD, we’ll nearly double our total addressable market while providing the most comprehensive, integrated healthcare navigation experience available," Rajeev Singh, Accolade CEO.